Influence of TGF-β1 expression on the development of tubulointerstitial fibrosis in patients with primary chronic glomerulonephritis
- Authors: Mukhtarova A.V.1, Batyushin M.M.1, Sinelnik E.A.2, Antipova N.V.2, Gadaborsheva H.Z.1
-
Affiliations:
- Rostov State Medical University of the Ministry of Healthcare of Russia
- Regional Clinical Hospital No. 2, Rostov-on-Don
- Issue: Vol 7, No 7 (2021)
- Pages: 71-76
- Section: Articles
- URL: https://journals.eco-vector.com/2412-4036/article/view/288485
- DOI: https://doi.org/10.18565/therapy.2021.7.71-76
- ID: 288485
Cite item
Abstract
Full Text
About the authors
Aytan V. Mukhtarova
Rostov State Medical University of the Ministry of Healthcare of Russia
Email: ayka.mukhtarova@gmail.com
the Head of the dialysis unit No. 2 ”LLC DC NEFROS-DON", post-graduate student of the Internal Medicine Department No. 2
Mikhail M. Batyushin
Rostov State Medical University of the Ministry of Healthcare of RussiaMD, PhD, DMedSci professor, professor of the internal medicine Department of No. 2, the Head of the nephrology Department
Elena A. Sinelnik
Regional Clinical Hospital No. 2, Rostov-on-Don
Email: ob2p@mail.ru
Candidate of Medical Sciences, the Head of the pathology Department
Natalia V. Antipova
Regional Clinical Hospital No. 2, Rostov-on-Don
Email: ob2p@mail.ru
the Head of the nephrology Department
Hani Z. Gadaborsheva
Rostov State Medical University of the Ministry of Healthcare of RussiaCandidate of Medical Sciences, Nephrologist
References
- Семешина О.В., Лучанинова В.Н., Маркелова Е.В. с соавт. Особенности экскреции цитокинов с мочой при хронической болезни почек у детей. Клиническая нефрология. 2017; 3: 46-53.
- Isaka Y. Targeting TGF-β signaling in kidney fibrosis. Int J. Mol Sci. 2018; 19(9): 2532. doi: 10.3390/ijms19092532.
- Finnson K.W., Almadani Y., Philip А. Non-canonical (non-SMAD2/3) TGF-B signaling in fibrosis: Mechanisms and targets. Semin Cell Dev Biol. 2020; 101: 115-22. doi: 10.1016/j.semcdb.2019.11.013.
- David C.J., Massague J. Contextual determinants of TGFβ action in development, immunity and cancer. Nat Rev Mol Cell Biol. 2018; 19(7): 419-35. doi: 10.1038/s41 580-018-0007-0.
- Москалев А.В., Рудой А.С., Апчел А.В. с соавт. Особенности биологии трансформирующего ростового фактора В. и иммунопатология. Вестник Российской военно-медицинской академии. 2016; 2: 206-216.
- Соколова А.В., Драгунов Д.О., Арутюнов Г.П. с соавт. Влияние избыточного потребления соли на изменение тубулоин-терстициальной ткани почек пациентов с гипертонической болезнью. Морфологическое исследование. Клиническая нефрология. 2017; 4: 42-50.
- Gewin L.S. Renal fibrosis: Primacy of the proximal tubule. Matrix Biol. 2018; 68-69: 248-62. doi: 10.1016/j.matbio.2018.02.006.
- Gu Y.Y., Dou J.Y., Huang X.R. et al. Transforming growth factor-B and long non-coding RNA in renal inflammation and fibrosis. Front Physiol. 2021; 12: 684236. doi: 10.3389/fphys.2021.684236.
- Gu Y.Y., Liu X.S., Huang X.R. et al. Diverse role of TGF-β in kidney disease. Front Cell Dev Biol. 2020; 8: 123. doi: 10.3389/ fcell.2020.00123.
- Kim K., Sheppard D., Chapman H. TGF-β1 signaling and tissue fibrosis. Cold Spring Harb Perspect Biol. 2018; 10(4): 1-34. doi: 10.1101/cshperspect.a022293.
- Harskamp L.R., Gansevoort R.T., Van Goor H., Meijer E. The epidermal growth factor receptor pathway in chronic kidney diseases. Nat Rev Nephrol. 2016; 12(8): 496-506. doi: 10.1038/nrneph.2016.91.
- Батюшин М.М., Броновицкая Н.А., Гасанов М.З., Сарвилина И.В. Протеомный спектр мочи при нефропатиях различного генеза. Клиническая нефрология. 2014; 1:50-54